340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

CMS Rule Likely Won’t Block Hospitals Using 340B in New Offsite Locations

 

November 3, 2016—A new federal rule that changes how Medicare pays for services at certain hospital off-campus departments likely won't prevent hospitals from enrolling the sites in the 340B drug discount program in 2017. On Nov. 1, the Centers for Medicare and Medicaid Services published a final rule implementing the site neutrality provision in Section 603 of the … [Read more...]

Delaware Drops Medicaid 340B Carve-Out Requirement

 

November 2, 2016—Delaware Medicaid has dropped what was thought to be a first-of-its-kind state requirement that would have barred healthcare providers from using 340B-purchased drugs for Medicaid beneficiaries. … [Read more...]

340B Hospitals Ask DOJ for EpiPen Overcharge Investigation

 

November 1, 2016—Hospitals and health systems in the 340B drug discount program have asked the U.S. Justice Department to investigate whether drugmaker Mylan overcharged 340B healthcare providers for EpiPen anaphylaxis rescue auto-injectors. … [Read more...]

340B Is Good For Americans. Why Is Big Pharma Trying to Gut it?

 

November 1, 2016—Thanks to the money its saves from being in the 340B drug discount program, a Virginia hospital could afford to perform heart surgery on an unemployed, uninsured man, put him on a blood thinner, and then keep close tabs on his health post-discharge – all for free. A Boston 340B hospital likewise can afford to keep first responders supplied with opioid overdose … [Read more...]

Specialty Drug Claims Costs Expected to Rise Almost 20 Percent

 

October 27, 2016—Healthcare payers expect claims costs for specialty and biotech drugs to rise by almost 20 percent next year, a leading health benefits consulting firm says. … [Read more...]

Investors Press Drug Companies About Unjustified Price Increases

 

October 25, 2016—Socially responsible investors want 17 leading U.S. and foreign drug companies to provide "more comprehensive disclosure about the rationale for price increases." … [Read more...]

OMB Reviewing 340B Final Rule Creating Fines for Overcharges

 

October 24, 2016—The Department of Health and Human Services' final 340B program rule setting standards for calculating ceiling prices and implementing civil monetary penalties for drugmakers that “knowingly” and “intentionally” overcharge covered entities for covered outpatient drugs is a step closer to release. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health